Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Haematologica
|
December 4, 2025
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancer
Olisaemeka Ogbue, Yael Kusne, Osama Mosalem, et al.
Urology
|
February 5, 2026
A Simplified Prediction Tool for Metastasis after Nephrectomy with Venous Tumor Thrombectomy for RCC
Daniel S Roberson, Spyridon P Basourakos, John C Cheville, et al.
Blood
|
October 28, 2017
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
Nancy L Bartlett, Brian A Costello, Betsy R LaPlant, et al.
European Urology
|
August 18, 2014
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
Xiaoyi Huang, Tiezheng Yuan, Meihua Liang, et al.
Nature Communications
|
April 1, 2026
Whole-proteome phage immunoprecipitation sequencing reveals germ cell tumor-specific immunosignature
M Bakri Hammami, Andrew M Knight, Haidara Kherbek, et al.
European Urology
|
December 4, 2021
A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis
Sarah P Psutka, Roman Gulati, Michael A S Jewett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810
Leonard J Appleman, Se Eun Kim, Wayne B Harris, et al.
Journal of Pain and Symptom Management
|
May 5, 2025
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors
Regina M Koch, Miguel Muniz, Candy S Peskey, et al.
Frontiers in Oncology
|
April 13, 2023
Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy
Roman Kowalchuk, Trey C Mullikin, William Breen, et al.
Practical Radiation Oncology
|
February 13, 2022
Development and Internal Validation of a Recursive Partitioning Analysis-Based Model Predictive of Pain Flare Incidence After Spine Stereotactic Body Radiation Therapy
Roman O Kowalchuk, Trey C Mullikin, William S Harmsen, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Haematologica
|
December 4, 2025
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancer
Olisaemeka Ogbue, Yael Kusne, Osama Mosalem, et al.
Urology
|
February 5, 2026
A Simplified Prediction Tool for Metastasis after Nephrectomy with Venous Tumor Thrombectomy for RCC
Daniel S Roberson, Spyridon P Basourakos, John C Cheville, et al.
Blood
|
October 28, 2017
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
Nancy L Bartlett, Brian A Costello, Betsy R LaPlant, et al.
European Urology
|
August 18, 2014
Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
Xiaoyi Huang, Tiezheng Yuan, Meihua Liang, et al.
Nature Communications
|
April 1, 2026
Whole-proteome phage immunoprecipitation sequencing reveals germ cell tumor-specific immunosignature
M Bakri Hammami, Andrew M Knight, Haidara Kherbek, et al.
European Urology
|
December 4, 2021
A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis
Sarah P Psutka, Roman Gulati, Michael A S Jewett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810
Leonard J Appleman, Se Eun Kim, Wayne B Harris, et al.
Journal of Pain and Symptom Management
|
May 5, 2025
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors
Regina M Koch, Miguel Muniz, Candy S Peskey, et al.
Frontiers in Oncology
|
April 13, 2023
Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy
Roman Kowalchuk, Trey C Mullikin, William Breen, et al.
Practical Radiation Oncology
|
February 13, 2022
Development and Internal Validation of a Recursive Partitioning Analysis-Based Model Predictive of Pain Flare Incidence After Spine Stereotactic Body Radiation Therapy
Roman O Kowalchuk, Trey C Mullikin, William S Harmsen, et al.
Page
of 12